Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type | isBackUp |
A1 | 1 | 45 | F | Uterus | Endometrioid adenocarcinoma | 2 | T2N0M0 | II | Malignant | N |
A2 | 2 | 43 | F | Uterus | Endometrioid adenocarcinoma | 2 | T4N0M0 | IVA | Malignant | N |
A3 | 3 | 56 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
A4 | 4 | 64 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1aN0M0 | IA | Malignant | N |
A5 | 5 | 42 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
A6 | 6 | 45 | F | Uterus | Endometrioid adenocarcinoma | 2 | T2N0M0 | II | Malignant | N |
A7 | 7 | 43 | F | Uterus | Endometrioid adenocarcinoma | 2 | T4N0M0 | IVA | Malignant | N |
A8 | 8 | 56 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
A9 | 9 | 64 | F | Uterus | Endometrioid adenocarcinoma (chronic inflammation of smooth muscle) | * | T1aN0M0 | IA | Malignant | N |
A10 | 10 | 42 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
B1 | 11 | 53 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | N |
B2 | 12 | 62 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
B3 | 13 | 40 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
B4 | 14 | 47 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | N |
B5 | 15 | 56 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
B6 | 16 | 53 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | N |
B7 | 17 | 62 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
B8 | 18 | 40 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
B9 | 19 | 47 | F | Uterus | Endometrioid adenocarcinoma (chronic inflammation of smooth muscle) | * | T1bN0M0 | IB | Malignant | N |
B10 | 20 | 56 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
C1 | 21 | 56 | F | Uterus | Endometrioid adenocarcinoma | 2 | T3N1M0 | IIIC | Malignant | N |
C2 | 22 | 48 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
C3 | 23 | 61 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1cN0M0 | IC | Malignant | N |
C4 | 24 | 45 | F | Uterus | Endometrioid adenocarcinoma | 2 | T3N1M0 | IIIC | Malignant | N |
C5 | 25 | 51 | F | Uterus | Endometrioid adenocarcinoma (chronic inflammation of smooth muscle) | * | T2bN0M0 | IIB | Malignant | N |
C6 | 26 | 56 | F | Uterus | Endometrioid adenocarcinoma | 2 | T3N1M0 | IIIC | Malignant | N |
C7 | 27 | 48 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
C8 | 28 | 61 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1cN0M0 | IC | Malignant | N |
C9 | 29 | 45 | F | Uterus | Endometrioid adenocarcinoma | 2 | T3N1M0 | IIIC | Malignant | N |
C10 | 30 | 51 | F | Uterus | Endometrioid adenocarcinoma (sparse) | * | T2bN0M0 | IIB | Malignant | N |
D1 | 31 | 43 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
D2 | 32 | 23 | F | Uterus | Endometrioid adenocarcinoma | 2 | T3N2M0 | IIIC | Malignant | N |
D3 | 33 | 46 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1cN0M0 | IC | Malignant | N |
D4 | 34 | 54 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1N0M0 | I | Malignant | N |
D5 | 35 | 48 | F | Uterus | Endometrioid adenocarcinoma with squamous metaplasia | 3 | T2N0M0 | II | Malignant | N |
D6 | 36 | 43 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
D7 | 37 | 23 | F | Uterus | Endometrioid adenocarcinoma | 2 | T3N2M0 | IIIC | Malignant | N |
D8 | 38 | 46 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1cN0M0 | IC | Malignant | N |
D9 | 39 | 54 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1N0M0 | I | Malignant | N |
D10 | 40 | 48 | F | Uterus | Endometrioid adenocarcinoma with squamous metaplasia | 3 | T2N0M0 | II | Malignant | N |
E1 | 41 | 62 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | N |
E2 | 42 | 56 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N1M0 | IIIC | Malignant | N |
E3 | 43 | 51 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1cN0M0 | IC | Malignant | N |
E4 | 44 | 55 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
E5 | 45 | 45 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1N0M0 | I | Malignant | N |
E6 | 46 | 62 | F | Uterus | Endometrioid adenocarcinoma (sparse) | * | T1bN0M0 | IB | Malignant | N |
E7 | 47 | 56 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N1M0 | IIIC | Malignant | N |
E8 | 48 | 51 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1cN0M0 | IC | Malignant | N |
E9 | 49 | 55 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
E10 | 50 | 45 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1N0M0 | I | Malignant | N |
F1 | 51 | 45 | F | Uterus | Endometrioid adenocarcinoma | 2 | T2N0M0 | II | Malignant | N |
F2 | 52 | 43 | F | Uterus | Endometrioid adenocarcinoma | 2 | T4N0M0 | IVA | Malignant | N |
F3 | 53 | 56 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
F4 | 54 | 64 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1aN0M0 | IA | Malignant | N |
F5 | 55 | 42 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
F6 | 56 | 45 | F | Uterus | Endometrioid adenocarcinoma | 2 | T2N0M0 | II | Malignant | N |
F7 | 57 | 43 | F | Uterus | Endometrioid adenocarcinoma | 2 | T4N0M0 | IVA | Malignant | N |
F8 | 58 | 56 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
F9 | 59 | 64 | F | Uterus | Endometrioid adenocarcinoma (chronic inflammation of smooth muscle) | * | T1aN0M0 | IA | Malignant | N |
F10 | 60 | 42 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
G1 | 61 | 53 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | N |
G2 | 62 | 62 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
G3 | 63 | 40 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
G4 | 64 | 47 | F | Uterus | Endometrioid adenocarcinoma (chronic inflammation of smooth muscle) | * | T1bN0M0 | IB | Malignant | N |
G5 | 65 | 56 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
G6 | 66 | 53 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | N |
G7 | 67 | 62 | F | Uterus | Endometrioid adenocarcinoma (sparse) | 2 | T1N0M0 | I | Malignant | N |
G8 | 68 | 40 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
G9 | 69 | 47 | F | Uterus | Endometrioid adenocarcinoma (chronic inflammation of smooth muscle) | * | T1bN0M0 | IB | Malignant | N |
G10 | 70 | 56 | F | Uterus | Endometrioid adenocarcinoma (sparse) | 2 | T1N0M0 | I | Malignant | N |
H1 | 71 | 56 | F | Uterus | Endometrioid adenocarcinoma | 2 | T3N1M0 | IIIC | Malignant | N |
H2 | 72 | 48 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
H3 | 73 | 61 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1cN0M0 | IC | Malignant | N |
H4 | 74 | 45 | F | Uterus | Endometrioid adenocarcinoma | 2 | T3N1M0 | IIIC | Malignant | N |
H5 | 75 | 51 | F | Uterus | Endometrioid adenocarcinoma (chronic inflammation of smooth muscle) | * | T2bN0M0 | IIB | Malignant | N |
H6 | 76 | 56 | F | Uterus | Endometrioid adenocarcinoma (sparse) | 2 | T3N1M0 | IIIC | Malignant | N |
H7 | 77 | 48 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
H8 | 78 | 61 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1cN0M0 | IC | Malignant | N |
H9 | 79 | 45 | F | Uterus | Endometrioid adenocarcinoma | 2 | T3N1M0 | IIIC | Malignant | N |
H10 | 80 | 51 | F | Uterus | Endometrioid adenocarcinoma | 2 | T2bN0M0 | IIB | Malignant | N |
I1 | 81 | 43 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
I2 | 82 | 23 | F | Uterus | Endometrioid adenocarcinoma | 2 | T3N2M0 | IIIC | Malignant | N |
I3 | 83 | 46 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1cN0M0 | IC | Malignant | N |
I4 | 84 | 54 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
I5 | 85 | 48 | F | Uterus | Endometrioid adenocarcinoma with squamous metaplasia | 3 | T2N0M0 | II | Malignant | N |
I6 | 86 | 43 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
I7 | 87 | 23 | F | Uterus | Endometrioid adenocarcinoma | 2 | T3N2M0 | IIIC | Malignant | N |
I8 | 88 | 46 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1cN0M0 | IC | Malignant | N |
I9 | 89 | 54 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1N0M0 | I | Malignant | N |
I10 | 90 | 48 | F | Uterus | Endometrioid adenocarcinoma with squamous metaplasia | 3 | T2N0M0 | II | Malignant | N |
J1 | 91 | 62 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | N |
J2 | 92 | 56 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N1M0 | IIIC | Malignant | N |
J3 | 93 | 51 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1cN0M0 | IC | Malignant | N |
J4 | 94 | 55 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
J5 | 95 | 45 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1N0M0 | I | Malignant | N |
J6 | 96 | 62 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | N |
J7 | 97 | 56 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N1M0 | IIIC | Malignant | N |
J8 | 98 | 51 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1cN0M0 | IC | Malignant | N |
J9 | 99 | 55 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant | N |
J10 | 100 | 45 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1N0M0 | I | Malignant | N |
Tissue Marker |